Published in N Engl J Med on March 19, 2013
KULeuven Intensive Insulin Therapy Study in Medical Intensive Care Patients | NCT00115479
Dynamic pituitary-adrenal interactions in response to cardiac surgery. Crit Care Med (2015) 1.64
Diminished adrenal sensitivity to endogenous and exogenous adrenocorticotropic hormone in critical illness: a prospective cohort study. Crit Care (2015) 1.46
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab (2016) 1.43
Metabolomic derangements are associated with mortality in critically ill adult patients. PLoS One (2014) 1.08
Noninvasive urinary metabolomic profiling identifies diagnostic and prognostic markers in lung cancer. Cancer Res (2014) 1.00
Reduced cortisol metabolism during critical illness. N Engl J Med (2013) 0.91
Reduced cortisol metabolism during critical illness. N Engl J Med (2013) 0.91
Reduced cortisol metabolism during critical illness. N Engl J Med (2013) 0.89
Reduced cortisol metabolism during critical illness. N Engl J Med (2013) 0.88
Reduced nocturnal ACTH-driven cortisol secretion during critical illness. Am J Physiol Endocrinol Metab (2014) 0.86
Paradoxical benefits of psychological stress in inflammatory dermatoses models are glucocorticoid mediated. J Invest Dermatol (2014) 0.86
Glucocorticoids Acutely Increase Brown Adipose Tissue Activity in Humans, Revealing Species-Specific Differences in UCP-1 Regulation. Cell Metab (2016) 0.84
Reduced cortisol metabolism during critical illness. N Engl J Med (2013) 0.82
Cortisol response to operative stress with anesthesia in healthy children. J Clin Endocrinol Metab (2013) 0.81
Hypopituitarism in Traumatic Brain Injury-A Critical Note. J Clin Med (2015) 0.80
Plasma cytokine levels predict response to corticosteroids in septic shock. Intensive Care Med (2016) 0.79
Relative adrenal insufficiency in mice deficient in 5α-reductase 1. J Endocrinol (2014) 0.78
The Role of ACTH and Corticosteroids for Sepsis and Septic Shock: An Update. Front Endocrinol (Lausanne) (2016) 0.78
Adrenal dysfunction in critically ill patients. N Engl J Med (2013) 0.78
Corticosteroids for severe influenza pneumonia: A critical appraisal. World J Crit Care Med (2016) 0.78
Steroid responses in sepsis: some novel thinking that may provide new insight. Crit Care (2013) 0.77
Hypothalamic-pituitary-adrenal axis in lethal canine Staphylococcus aureus pneumonia. Am J Physiol Endocrinol Metab (2014) 0.77
Impairment of neutrophilic glucocorticoid receptor function in patients treated with steroids for septic shock. Intensive Care Med Exp (2015) 0.77
Temporal patterns, heterogeneity, and stability of diurnal cortisol rhythms in children with autism spectrum disorder. Psychoneuroendocrinology (2015) 0.77
Clinical impact of stress dose steroids in patients with septic shock: insights from the PROWESS-Shock trial. Crit Care (2015) 0.77
New prognostic markers in liver cirrhosis. World J Hepatol (2015) 0.76
Endocrinologic Diseases in Pediatric Cardiac Intensive Care. Pediatr Crit Care Med (2016) 0.75
Serum cortisol level and adrenal reserve as a predictor of patients' outcome after successful cardiopulmonary resuscitation. J Cardiovasc Thorac Res (2016) 0.75
Glucocorticoid Receptor Polymorphisms and Outcomes in Pediatric Septic Shock. Pediatr Crit Care Med (2017) 0.75
Adrenal function: Cortisol metabolism during acute stress--an (IC)U turn. Nat Rev Endocrinol (2013) 0.75
Cortisol Correlates with Severity of Illness and Poorly Reflects Adrenal Function in Pediatric Acute Respiratory Distress Syndrome. J Pediatr (2016) 0.75
What's new on the HPA axis? Intensive Care Med (2015) 0.75
Cortisol is an associated-risk factor of brain dysfunction in patients with severe sepsis and septic shock. Biomed Res Int (2014) 0.75
Stress hormones and posttraumatic stress symptoms following paediatric critical illness: an exploratory study. Eur Child Adolesc Psychiatry (2016) 0.75
Cosyntropin-Stimulated Serum Free Cortisol in Healthy, Adrenally Insufficient, and Mildly Cirrhotic Populations. J Clin Endocrinol Metab (2015) 0.75
Selection and early clinical evaluation of the brain-penetrant 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor UE2343 (Xanamem(TM) ). Br J Pharmacol (2016) 0.75
11β-Hydroxysteroid dehydrogenase activity in the brain does not contribute to systemic interconversion of cortisol and cortisone in healthy men. J Clin Endocrinol Metab (2014) 0.75
Glucocorticoids as an emerging pharmacologic agent for cardiopulmonary resuscitation. Cardiovasc Drugs Ther (2014) 0.75
Cortisol Response to Low-dose (1 µg) ACTH Stimulation for the Prediction of Outcome in Patients with Systemic Inflammatory Response Syndrome. J Med Biochem (2016) 0.75
What's new in acute liver failure? Intensive Care Med (2014) 0.75
Prednisone compared to methylprednisolone in the polymyalgia rheumatica treatment. Rheumatol Int (2014) 0.75
Relative Adrenal Insufficiency in Patients with Cirrhosis: A Systematic Review and Meta-Analysis. Dig Dis Sci (2017) 0.75
APACHE II: a severity of disease classification system. Crit Care Med (1985) 69.83
Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA (2002) 16.37
Hydrocortisone therapy for patients with septic shock. N Engl J Med (2008) 15.85
A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA (2000) 4.92
11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev (2004) 3.56
Obesity and gender influence cortisol secretion and metabolism in man. J Clin Endocrinol Metab (1998) 2.41
Cortisol response in relation to the severity of stress and illness. J Clin Endocrinol Metab (2005) 2.19
Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: possible role of endothelin and atrial natriuretic hormone. J Clin Endocrinol Metab (1995) 2.03
11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr Rev (1997) 1.91
The general adaptation syndrome and the diseases of adaptation. J Clin Endocrinol Metab (1946) 1.82
High fluid intake increases urine free cortisol excretion in normal subjects. J Clin Endocrinol Metab (1998) 1.70
Dissociation of ACTH and glucocorticoids. Trends Endocrinol Metab (2008) 1.68
Comparative studies on adrenal cortical function and cortisol metabolism in healthy adults and in patients with shock due to infection. J Clin Invest (1958) 1.67
Cortisol response to critical illness: effect of intensive insulin therapy. J Clin Endocrinol Metab (2006) 1.60
Metabolism of adrenal steroids in dying patients. J Clin Endocrinol Metab (1956) 1.56
Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding globulin. J Steroid Biochem (1987) 1.46
Clinical review 104: Adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs. J Clin Endocrinol Metab (1999) 1.41
Cortisol release from adipose tissue by 11beta-hydroxysteroid dehydrogenase type 1 in humans. Diabetes (2008) 1.35
11 beta-Hydroxysteroid dehydrogenase activity in Cushing's syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab (1995) 1.33
Distinguishing the activities of 11beta-hydroxysteroid dehydrogenases in vivo using isotopically labeled cortisol. J Clin Endocrinol Metab (2002) 1.32
The contribution of visceral adipose tissue to splanchnic cortisol production in healthy humans. Diabetes (2005) 1.32
Evolution of steroid-5alpha-reductases and comparison of their function with 5beta-reductase. Gen Comp Endocrinol (2009) 1.25
Urinary free cortisol and cortisone excretion in healthy individuals: influence of water loading. Steroids (2006) 1.25
Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man. Clin Endocrinol (Oxf) (1996) 1.23
Additional value of measurement of urinary cortisone and unconjugated cortisol metabolites in assessing the activity of 11 beta-hydroxysteroid dehydrogenase in vivo. Clin Endocrinol (Oxf) (1997) 1.21
The altered adrenal axis and treatment with glucocorticoids during critical illness. Nat Clin Pract Endocrinol Metab (2008) 1.20
Liver is the site of splanchnic cortisol production in obese nondiabetic humans. Diabetes (2008) 1.17
Recycling between cortisol and cortisone in human splanchnic, subcutaneous adipose, and skeletal muscle tissues in vivo. Diabetes (2012) 1.13
Reduced adipose glucocorticoid reactivation and increased hepatic glucocorticoid clearance as an early adaptation to high-fat feeding in Wistar rats. Endocrinology (2004) 1.09
The hypothalamic-pituitary-adrenal response to critical illness. Best Pract Res Clin Endocrinol Metab (2001) 1.08
Critical illness evokes elevated circulating bile acids related to altered hepatic transporter and nuclear receptor expression. Hepatology (2011) 1.01
Inhibition of 11beta-hydroxysteroid dehydrogenase by bile acids in rats with cirrhosis. Hepatology (1999) 0.99
Reduced activity of 11 beta-hydroxysteroid dehydrogenase in patients with cholestasis. J Clin Invest (2001) 0.99
Bile acids modulate glucocorticoid metabolism and the hypothalamic-pituitary-adrenal axis in obstructive jaundice. J Hepatol (2010) 0.99
Adrenal insufficiency in the surgical intensive care unit patient. J Trauma (1997) 0.94
Defective ring A reduction of cortisol as the major metabolic error in the syndrome of apparent mineralocorticoid excess. J Clin Endocrinol Metab (1992) 0.92
Chenodeoxycholic acid and deoxycholic acid inhibit 11 beta-hydroxysteroid dehydrogenase type 2 and cause cortisol-induced transcriptional activation of the mineralocorticoid receptor. J Biol Chem (2002) 0.91
How will we know if 11beta-hydroxysteroid dehydrogenases are important in common diseases. Clin Endocrinol (Oxf) (2000) 0.86
Intensive insulin therapy in the medical ICU. N Engl J Med (2006) 22.37
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Early versus late parenteral nutrition in critically ill adults. N Engl J Med (2011) 12.10
Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study. Lancet (2009) 6.44
Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med (2003) 5.92
ESPEN Guidelines on Parenteral Nutrition: intensive care. Clin Nutr (2009) 4.11
Serum potassium levels and mortality in acute myocardial infarction. JAMA (2012) 4.09
Nutrition in the acute phase of critical illness. N Engl J Med (2014) 4.02
Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2012) 4.02
Tight blood glucose control with insulin in the ICU: facts and controversies. Chest (2007) 3.79
Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes (2006) 3.56
Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases. Clin Infect Dis (2009) 3.33
Neurocognitive development of children 4 years after critical illness and treatment with tight glucose control: a randomized controlled trial. JAMA (2012) 3.16
Dynamic characteristics of blood glucose time series during the course of critical illness: effects of intensive insulin therapy and relative association with mortality. Crit Care Med (2010) 3.16
Concern Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J (2009) 3.14
Impact of early parenteral nutrition on muscle and adipose tissue compartments during critical illness. Crit Care Med (2013) 2.81
Acute outcomes and 1-year mortality of intensive care unit-acquired weakness. A cohort study and propensity-matched analysis. Am J Respir Crit Care Med (2014) 2.68
Amino acid concentrations in critically ill children following cardiac surgery*. Pediatr Crit Care Med (2014) 2.65
Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med (2007) 2.41
Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study. Intensive Care Med (2012) 2.39
Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med (2004) 2.39
Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. Am J Respir Crit Care Med (2006) 2.22
Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients. Crit Care Med (2006) 2.21
Intergenerational consequences of fetal programming by in utero exposure to glucocorticoids in rats. Am J Physiol Regul Integr Comp Physiol (2004) 2.15
Cytomegalovirus serostatus and outcome in nonimmunocompromised critically ill patients. Crit Care Med (2012) 2.14
Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes (2004) 2.12
Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest (2005) 2.11
Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients. J Clin Endocrinol Metab (2010) 2.10
Polymorphisms in innate immunity genes predispose to bacteremia and death in the medical intensive care unit. Crit Care Med (2009) 2.10
Pressure autoregulation monitoring and cerebral perfusion pressure target recommendation in patients with severe traumatic brain injury based on minute-by-minute monitoring data. J Neurosurg (2014) 2.04
Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome. J Endocrinol (2008) 2.01
Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab (2003) 1.93
Bone turnover in prolonged critical illness: effect of vitamin D. J Clin Endocrinol Metab (2003) 1.92
Insufficient autophagy contributes to mitochondrial dysfunction, organ failure, and adverse outcome in an animal model of critical illness. Crit Care Med (2013) 1.78
Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet (2005) 1.78
Insulin response in relation to insulin sensitivity: an appropriate beta-cell response in black South African women. Diabetes Care (2009) 1.78
Pharmacist- versus physician-acquired medication history: a prospective study at the emergency department. Qual Saf Health Care (2010) 1.77
Abnormal cortisol metabolism and tissue sensitivity to cortisol in patients with glucose intolerance. J Clin Endocrinol Metab (2002) 1.74
Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity. J Clin Endocrinol Metab (2002) 1.74
Clinical review: Consensus recommendations on measurement of blood glucose and reporting glycemic control in critically ill adults. Crit Care (2013) 1.72
Clinical review: Critical illness polyneuropathy and myopathy. Crit Care (2008) 1.69
Endocrine, metabolic, and morphologic alterations of adipose tissue during critical illness. Crit Care Med (2013) 1.67
Tight blood glucose control is renoprotective in critically ill patients. J Am Soc Nephrol (2008) 1.67
Cortisol response to critical illness: effect of intensive insulin therapy. J Clin Endocrinol Metab (2006) 1.60
Tight glycemic control protects the myocardium and reduces inflammation in neonatal heart surgery. Ann Thorac Surg (2010) 1.59
American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract (2004) 1.59
Novel methods to predict increased intracranial pressure during intensive care and long-term neurologic outcome after traumatic brain injury: development and validation in a multicenter dataset. Crit Care Med (2013) 1.58
7-oxysterols modulate glucocorticoid activity in adipocytes through competition for 11beta-hydroxysteroid dehydrogenase type. Endocrinology (2008) 1.58
Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality? Crit Care Med (2005) 1.58
Genotype-phenotype correlation in 153 adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: analysis of the United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE) cohort. J Clin Endocrinol Metab (2013) 1.58
Muscle atrophy and preferential loss of myosin in prolonged critically ill patients. Crit Care Med (2012) 1.57
5α-reductase type 1 modulates insulin sensitivity in men. J Clin Endocrinol Metab (2014) 1.55
Association between elevated blood glucose and outcome in acute heart failure: results from an international observational cohort. J Am Coll Cardiol (2013) 1.55
11Beta-hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics. Proc Natl Acad Sci U S A (2004) 1.52
Reducing mortality in sepsis: new directions. Crit Care (2002) 1.52
Differences in cortisol concentrations in South Asian and European men living in the United Kingdom. Clin Endocrinol (Oxf) (2006) 1.51
Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. J Clin Endocrinol Metab (2003) 1.50
Regulation of the somatotropic axis by intensive insulin therapy during protracted critical illness. J Clin Endocrinol Metab (2004) 1.50